Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired ...
Arcjet today announced Advanced Bot Signals, a new capability that helps developers protect critical application flows from modern browser automation without interrupting legitimate users with ...
First-in-class treatment of life-threatening, drug-resistant Acinetobacter baumannii infections advancing toward Phase II clinical proof-of-concept JERUSALEM, Israel, June 3, 2026 -- Omnix Medical, a ...
CNBC's "Options Action" is your front row seat to the fastest-growing corner of the markets. With guidance from industry experts, exclusive data, and the latest news, Options Action explains complex ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results